Differentiation between etrolizumab (rhumab beta7) and placebo in the eucalyptus phase ii randomized double-blind placebo-controlled induction study to evaluate efficacy and safety in patients with refractory moderate-to-severely active ulcerative colitis

Authors
Category Primary study
JournalGastroenterology
Year 2013
This article has no abstract
Epistemonikos ID: ac8c84e82d39a8cfa46938fac9299322484a6452
First added on: Feb 05, 2025